ScripsAmerica's Distributor, PIMD International, Reports Record-High Monthly Revenue in January of over $135,000
ScripsAmerica's Distributor, PIMD International, Reports Record-High Monthly Revenue in January of over $135,000
TYSONS CORNER, Va., Feb. 11, 2015 (GLOBE NEWSWIRE) -- ScripsAmerica Inc. (OTCBB:SCRC), today announced that the Company's owned distributor, PIMD International, LLC, ("PIMD"
, reported revenue of $137,031 during the month of January 2015. This represents PIMD's highest monthly revenue in the company's history.
ScripsAmerica acquired a 90% interest in the Florida-based pharmaceutical wholesaler in December 2014. PIMD International serves as a pharmaceutical wholesaler to pharmacies, hospitals, and physician's offices in the US and provides ScripsAmerica's customers with access to specific medications for its end users. PIMD will soon sell medical supplies in other healthcare settings through its website, www.pimdintl.com.
CEO of ScripsAmerica, Bob Schneiderman, commented, "PIMD's growth is a very positive development for ScripsAmerica as we generate revenue through our sourcing agreement with the company for pharmaceuticals and medical supplies. Driving sales for PIMD are our new product offerings. We expect revenue generated by our pharmaceutical wholesaler and distributor to continue this growth pattern in the coming months, ultimately increasing ScripsAmerica's shareholder value."
PIMD International is currently DEA-licensed to receive, store and ship Schedule 3 through Schedule 5 formulary pharmaceuticals. The company is also state-licensed to distribute pharmaceuticals in Florida, New Jersey, New York, Texas, Pennsylvania, Tennessee, Arizona, Kentucky, Alabama, Illinois, and Ohio and will continue to apply for additional state licenses throughout the United States.
About ScripsAmerica, Inc.
ScripsAmerica, Inc. is a supplier of prescription, OTC and nutraceutical drugs, delivering pharmaceutical products to a wide range of end users across the health care industry. End users include retail pharmacies, hospitals, long-term care facilities and government and home care agencies. For more information, visit www.ScripsAmerica.com.
Safe Harbor Statement
This release includes forward-looking statements, which are based on certain assumptions and reflects management's current expectations. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Some of these factors include: general global economic conditions; general industry and market conditions, sector changes and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increasing competition; availability and cost of capital; the ability to identify and develop and achieve commercial success; the level of expenditures necessary to maintain and improve the quality of services; changes in the economy; changes in laws and regulations, including codes and standards, intellectual property rights, and tax matters; or other matters not anticipated; our ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether a result of new information, future events or otherwise.
CONTACT: Seal Point Consulting, LLC
888-959-7095
ir@sealpointconsulting.com
(MORE TO FOLLOW) Dow Jones Newswires
February 11, 2015 08:00 ET (13:00 GMT)
ScripsAmerica's Distributor, PIMD International, Reports Record-High Monthly Revenue in January of over $135,000
TYSONS CORNER, Va., Feb. 11, 2015 (GLOBE NEWSWIRE) -- ScripsAmerica Inc. (OTCBB:SCRC), today announced that the Company's owned distributor, PIMD International, LLC, ("PIMD"
, reported revenue of $137,031 during the month of January 2015. This represents PIMD's highest monthly revenue in the company's history. ScripsAmerica acquired a 90% interest in the Florida-based pharmaceutical wholesaler in December 2014. PIMD International serves as a pharmaceutical wholesaler to pharmacies, hospitals, and physician's offices in the US and provides ScripsAmerica's customers with access to specific medications for its end users. PIMD will soon sell medical supplies in other healthcare settings through its website, www.pimdintl.com.
CEO of ScripsAmerica, Bob Schneiderman, commented, "PIMD's growth is a very positive development for ScripsAmerica as we generate revenue through our sourcing agreement with the company for pharmaceuticals and medical supplies. Driving sales for PIMD are our new product offerings. We expect revenue generated by our pharmaceutical wholesaler and distributor to continue this growth pattern in the coming months, ultimately increasing ScripsAmerica's shareholder value."
PIMD International is currently DEA-licensed to receive, store and ship Schedule 3 through Schedule 5 formulary pharmaceuticals. The company is also state-licensed to distribute pharmaceuticals in Florida, New Jersey, New York, Texas, Pennsylvania, Tennessee, Arizona, Kentucky, Alabama, Illinois, and Ohio and will continue to apply for additional state licenses throughout the United States.
About ScripsAmerica, Inc.
ScripsAmerica, Inc. is a supplier of prescription, OTC and nutraceutical drugs, delivering pharmaceutical products to a wide range of end users across the health care industry. End users include retail pharmacies, hospitals, long-term care facilities and government and home care agencies. For more information, visit www.ScripsAmerica.com.
Safe Harbor Statement
This release includes forward-looking statements, which are based on certain assumptions and reflects management's current expectations. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Some of these factors include: general global economic conditions; general industry and market conditions, sector changes and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increasing competition; availability and cost of capital; the ability to identify and develop and achieve commercial success; the level of expenditures necessary to maintain and improve the quality of services; changes in the economy; changes in laws and regulations, including codes and standards, intellectual property rights, and tax matters; or other matters not anticipated; our ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether a result of new information, future events or otherwise.
CONTACT: Seal Point Consulting, LLC
888-959-7095
ir@sealpointconsulting.com
(MORE TO FOLLOW) Dow Jones Newswires
February 11, 2015 08:00 ET (13:00 GMT)
